Generative AI Will Not End Human Oversight in Drug Safety, FDA Scientists Argue
FDA scientists argue that generative AI will transform drug safety surveillance into hybrid human-AI systems rather than fully automating pharmacovigilance, ...
FDA scientists argue that generative AI will transform drug safety surveillance into hybrid human-AI systems rather than fully automating pharmacovigilance, ...
Regulatory scientists at the UK's MHRA argue that unstandardised biofilm methods and unclear evidence pathways are stalling anti-biofilm innovation, and ...
FDA researchers developed ARTEMIS, a framework that distills thousands of monoclonal antibody papers into compact, steerable AI memory that outperforms ...
Peter Barton Hutt, the former FDA Chief Counsel and longtime Critical Path Institute board member who shaped modern food and ...
A George Mason statistician has received FDA funding to develop regulatory-grade frameworks that quantify how record linkage errors affect the ...
Chinese researchers validated a physiologically based pharmacokinetic model of roxithromycin and used it to run a virtual bioequivalence trial in ...
A new evidence map of 126 studies shows artificial intelligence can accelerate PFAS toxicology and risk assessment, but only when ...
A new European Commission draft regulation is reshaping how medical devices and diagnostics are approved, and researchers say only a ...
A new review proposes a five-stage, fit-for-purpose framework to validate lung-on-a-chip microdevices for respiratory disease modelling and drug testing.
TUCSON, Ariz., July 16, 2026 — Critical Path Institute’s® (C-Path) New Approach Methodologies Developer Coalition (NAMs-DC) has added Crown Bioscience ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine